N.E.W. Advisory Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8K Buy
235
+28
+14% +$4.2K ﹤0.01% 417
2026
Q1
$31.6K Hold
207
﹤0.01% 434
2025
Q4
$28.5K Hold
207
﹤0.01% 436
2025
Q3
$26.5K Hold
207
﹤0.01% 413
2025
Q2
$25K Sell
207
-7
-3% -$789 ﹤0.01% 419
2025
Q1
$23.9K Buy
+214
New +$22.8K ﹤0.01% 471

Other funds holding NVS

N.E.W. Advisory Services's NVS Position: Q2 2026 in Review

N.E.W. Advisory Services increased its Novartis (NVS) stake by 14% in Q2 2026, buying an estimated $4.2K and bringing the position to 235 shares worth $36.8K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

N.E.W. Advisory Services first reported a position in NVS in Q1 2025 and has held it in 6 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • N.E.W. Advisory Services held 235 shares of Novartis worth $36.8K as of Q2 2026.
  • N.E.W. Advisory Services bought 28 Novartis shares in Q2 2026, an estimated $4.2K.
  • Novartis made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #417 holding.
  • N.E.W. Advisory Services first reported a position in Novartis in Q1 2025 and has held it in 6 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.